IQVIA Holdings (LTS:0JDM) Days Sales Outstanding : 33.29 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is IQVIA Holdings Days Sales Outstanding?

IQVIA Holdings's average Accounts Receivable for the three months ended in Dec. 2023 was $1,411 Mil. IQVIA Holdings's Revenue for the three months ended in Dec. 2023 was $3,868 Mil. Hence, IQVIA Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 33.29.

The historical rank and industry rank for IQVIA Holdings's Days Sales Outstanding or its related term are showing as below:

LTS:0JDM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 28.54 Med: 37.09 Max: 43.96
Current: 33.33

During the past 13 years, IQVIA Holdings's highest Days Sales Outstanding was 43.96. The lowest was 28.54. And the median was 37.09.

LTS:0JDM's Days Sales Outstanding is ranked better than
88.44% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.32 vs LTS:0JDM: 33.33

IQVIA Holdings's Days Sales Outstanding increased from Dec. 2022 (30.19) to Dec. 2023 (33.29).

IQVIA Holdings Days Sales Outstanding Historical Data

The historical data trend for IQVIA Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQVIA Holdings Days Sales Outstanding Chart

IQVIA Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

42.65

40.05

32.31

32.98

34.13

IQVIA Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															30.19	33.48	32.92	32.83	33.29

Competitive Comparison of IQVIA Holdings's Days Sales Outstanding

For the Diagnostics & Research subindustry, IQVIA Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IQVIA Holdings's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Days Sales Outstanding falls into.

IQVIA Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

IQVIA Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1329	+	1473)	/	2 )	/	14984	*	365
=	1401					/	14984	*	365
=	34.13

IQVIA Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1349	+	1473)	/	2 )	/	3868	*	365 / 4
=	1411					/	3868	*	365 / 4
=	33.29

IQVIA Holdings (LTS:0JDM) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

IQVIA Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

IQVIA Holdings (LTS:0JDM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (LTS:0JDM) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

IQV:USA IQV:Mexico QTS:Germany I1QV34:Brazil

Address

2400 Ellis Road, Durham, NC, USA, 27703

Website

https://www.iqvia.com

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

IQVIA Holdings (LTS:0JDM) Headlines

No Headlines